Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MPM Capital
Biotech
New RNA biotech raises $300M in largest private round of 2023
ReNAgade Therapeutics, armed with $300 million, says preclinical data have uncovered up to 20 potential indications to tackle.
Max Bayer
May 23, 2023 6:30am
Umoja aims immunotherapies at the clinic with $210M raise
Jun 15, 2021 7:00am
Bhargava leaves Gilead to take up post at biotech investor MPM
Apr 14, 2021 8:10am
Aktis Oncology bags $72M in Novartis, BMS-backed series A
Mar 18, 2021 9:05am
ElevateBio nets $525M to bolster cell, gene therapy platform
Mar 15, 2021 6:30am
Orna debuts with $100M, engineered circular RNA treatments
Feb 24, 2021 6:00am